{"url":"https://lda.gov/api/v1/filings/3af071bf-a4a7-4eb6-ba60-87b0398f70c4/","filing_uuid":"3af071bf-a4a7-4eb6-ba60-87b0398f70c4","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2025,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/3af071bf-a4a7-4eb6-ba60-87b0398f70c4/print/","filing_document_content_type":"text/html","income":null,"expenses":"65000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"David Sanders","dt_posted":"2025-03-24T13:31:25-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"333 Twin Dolphin Drive","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Redwood City","registrant_state":"CA","registrant_zip":"94065","registrant":{"id":401103810,"url":"https://lda.gov/api/v1/registrants/401103810/","house_registrant_id":null,"name":"COHERUS BIOSCIENCES, INC.","description":"lobbying, advocacy, pharmaceutical company","address_1":"333 Twin Dolphin Drive","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Redwood City","state":"CA","state_display":"California","zip":"94065","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID SANDERS","contact_telephone":"+1 202-422-2375","dt_updated":"2026-07-27T16:44:38.833272-04:00"},"client":{"id":200183,"url":"https://lda.gov/api/v1/clients/200183/","client_id":12,"name":"COHERUS BIOSCIENCES, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-08-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80167,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":"Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":21,"name":"Office of Science & Technology Policy (OSTP)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":80167,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":116,"name":"Defense Advanced Research Projects Agency (DARPA)"},{"id":48,"name":"Defense Nuclear Facilities Safety Board"},{"id":33,"name":"Energy, Dept of"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":56,"name":"Federal Emergency Management Agency (FEMA)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":16,"name":"Natl Security Council (NSC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":10,"name":"Vice President of the U.S."},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}